EGFR Mutated Non-small Cell Lung Cancer Patients
2 clinical trials · Condition
◉ Watch EGFR Mutated Non-small Cell Lung Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer (NCT07315113) | Nuvectis Pharma, Inc. | 2025-12-18 |
| Retrospective Study in a NSCLC M+ p (NCT01795352) | AstraZeneca | 2013-03-01 |
Track EGFR Mutated Non-small Cell Lung Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.